Anti-type Ii collagen antibodies in collagen disease
Fukasawa, Y.; Kano, S.
Rinsho Byori. Japanese Journal of Clinical Pathology 41(8): 876-881
1993
ISSN/ISBN: 0047-1860 PMID: 8371503 Document Number: 408513
Using enzyme-linked immunosorbent assay (ELISA), we determined the incidence of serum IgG antibodies to native type II collagen in patients with collagen diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS) and overlap syndrome (OL). Raised serum IgG anti-type II collagen antibody levels were present in 11% of patients with RA, 30% with SLE, 44% with PSS and 42% with OL. There was, however, no correlation with clinical manifestations or other laboratory data.
Document emailed within 1 workday
Related Documents
Yoshino, K.; Ohashi, T.; Urushibata, T.; Kenmochi, M.; Akagi, M. 1996: Antibodies of type Ii collagen and immune complexes in Menière's disease Acta Oto-Laryngologica. Supplementum 522: 79-85Kalluri, R.; Torre, A.; Shield, C.F.; Zamborsky, E.D.; Werner, M.C.; Suchin, E.; Wolf, G.; Helmchen, U.M.; van den Heuvel, L.P.; Grossman, R.; Aradhye, S.; Neilson, E.G. 2000: Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies Transplantation 69(4): 679-683
Wiggins, R.; Goyal, M.; Merritt, S.; Killen, P.D. 1993: Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease Laboratory Investigation; A Journal of Technical Methods and Pathology 68(5): 557-565
Merritt, S.E.; Killen, P.D.; Phan, S.H.; Wiggins, R.C. 1990: Analysis of alpha 1 (I) procollagen alpha 1 (IV) collagen, and beta-actin mRNA in glomerulus and cortex of rabbits with experimental anti-glomerular basement membrane disease. Evidence for early extraglomerular collagen biosynthesis Laboratory Investigation; a Journal of Technical Methods and Pathology 63(6): 762-769
Burrai, I.; Henderson, B.; Knight, S.C.; Staines, N.A. 1985: Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen Clinical and Experimental Immunology 61(2): 368-372
Wang, H.; Feng, Z.; Zhu, J.; Chen, X.; Wu, X.; Li, J. 2017: Zaocys type Ii collagen regulates the balance of Treg/Th17 cells in mice with collagen-induced arthritis Clinical and Experimental Rheumatology 35(3): 452-461
Gintz, B.; Phelip, X.; Micouin, C.; Cabanel, G. 1975: Anti-nuclear antibodies in collagen diseases La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 51(9): 573-580
Gay, S.; Remberger, K.; Adelmann, B.C. 1975: Immunofluorescence microscopy studies with isolated type-specific antibodies against collagen type I, Ii and IIi in connective tissue diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1183-1185
Gay, S.; Remberger, K. 1976: Rheumatoid Arthritis: Immunohistochemical studies with antibodies against collagen type I, Ii and IIi Verhandlungen der Deutschen Gesellschaft für Pathologie 1976: 290-291
Rosenberg, A.M.; Hunt, D.W.; Petty, R.E. 1984: Antibodies to native type I collagen in childhood rheumatic diseases Journal of Rheumatology 11(4): 421-424
Cremer, M.A.; Hernandez, A.D.; Townes, A.S.; Stuart, J.M.; Kang, A.H. 1983: Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type Ii collagen Journal of Immunology 131(6): 2995-3000
Reshetnikov, N.N.; Popova, T.I. 1992: IgA, IgM and IgG levels and antibodies to native DNA and collagen type Ii in the perilymph of patients with otosclerosis Vestnik Otorinolaringologii 3: 14-16
Shoenfeld, Y.; Gilburd, B.; Hojnik, M.; Damianovich, M.; Hacham, S.; Kopolovic, Y.; Polak-Charcon, P.; Goldberg, I.; Afek, A.; Hun-Chi, L. 1995: Induction of Goodpasture antibodies to noncollagenous domain (NC1) of type IV collagen in mice by idiotypic manipulation Human Antibodies and Hybridomas 6(4): 122-128
Chiang, T.M.; Mainardi, C.L.; Seyer, J.M.; Kang, A.H. 1980: Collagen-platelet interaction. Type V(A-B) collagen induced platelet aggregation Journal of Laboratory and Clinical Medicine 95(1): 99-107
Adebajo, A.O.; Williams, R.O.; Williams, D.G.; Hazleman, B.L.; Maini, R.N. 1994: High levels of anti-type II collagen IgG in west African patients with rheumatoid arthritis Journal of Rheumatology 21(12): 2206-2208
Hara, A.; Watanabe, T.; Namimatsu, S. 1988: Type I like collagen appeared in vitreous disease Nippon Ganka Gakkai Zasshi 92(8): 1363-1368
Cook, A.D.; Mackay, I.R.; Cicuttini, F.M.; Rowley, M.J. 1997: IgG subclasses of antibodies to type Ii collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases Journal of Rheumatology 24(11): 2090-2096
Meyer, O.; Semmache, M.; Cyna, J.; Mitrovic, D.; Ryckewaert, A. 1983: Anti-collagen antibodies. their detection in rheumatoid polyarthritis, chronic atrophic polychondritis and various chronic inflammatory rheumatism Revue du Rhumatisme et des Maladies Osteo-Articulaires 50(7): 493-499
Kotaniemi, A.; Risteli, J.; Aho, K.; Hakala, M. 2003: Increased type i collagen degradation correlates with disease activity in reactive arthritis Clinical and Experimental Rheumatology 21(1): 95-98
Iribe, H.; Kabashima, H.; Koga, T. 1989: Antibody response against a possible arthritogenic epitope on human type Ii collagen induced by anti-idiotypic antibody Journal of Immunology 142(5): 1487-1494